Nanocarrier-Based Drug Delivery Systems for Lung Cancer: A Systematic Review and Meta-Analysis of Preclinical Studies
Pranvera Breznica Selmani, Arlinda Daka Grapci, Blerina Koshi, Zana Sllamniku Dalipi, Rozafa Koliqi · 2026
Read Nanocarrier-Based Drug Delivery Systems for Lung Cancer: A Systematic Review and Meta-Analysis of Preclinical Studies by Pranvera Breznica Selmani, Arlinda Daka Grapci, Blerina Koshi, Zana Sllamniku Dalipi, Rozafa Koliqi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13509827.txt.
Description
Pranvera Breznica Selmani, Arlinda Daka Grapci, Blerina Koshi, Zana Sllamniku Dalipi, and Rozafa Koliqi pool animal studies of tiny drug carriers for lung cancer chemotherapy, in a 2026 review. The group searched the literature through February 2025 and graded study quality with a standard tool for animal research. Thirty studies with 47 experiments in mice met the entry rules.
Carrier-based treatment shrank tumors far more than the same drugs given free, on average. Targeted carriers that home in on cancer cells showed the largest average gains, though plain carriers also helped. Results varied a great deal between studies, and differences in formulas and study design cloud direct comparison. The authors stress that the findings concern lab models only, support better standardized animal work, and do not prove benefit in patients.
Catalog record
| CREATOR | Pranvera Breznica Selmani, Arlinda Daka Grapci, Blerina Koshi, Zana Sllamniku Dalipi, Rozafa Koliqi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38720 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |